# Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy

> **NCT01018758** · PHASE2 · COMPLETED · sponsor: **Gruppo Italiano Studio Linfomi** · enrollment: 86 (actual)

## Conditions studied

- Chemotherapy-Induced Nausea and Vomiting
- Non Hodgkin's Lymphoma

## Interventions

- **DRUG:** Palonosetron

## Key facts

- **NCT ID:** NCT01018758
- **Lead sponsor:** Gruppo Italiano Studio Linfomi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018758, "Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01018758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*